Search Results - "Sirdesai, S."

Development of RBC transfusion indications and the collection of patient‐specific pre‐transfusion information by Yazer, M. H., Watering, L., Lozano, M., Sirdesai, S., Rushford, K., Wood, E. M., Yokoyama, A. P., Kutner, J. M., Lin, Y., Callum, J., Cserti‐Gazdewich, C., Lieberman, L., Pendergrast, J., Pendry, K., Murphy, M. F., Selleng, K., Greinacher, A., Marwaha, N., Sharma, R., Jain, A., Orlin, Y., Yahalom, V., Perseghin, P., Incontri, A., Masera, N., Okazaki, H., Ikeda, T., Nagura, Y., Zwaginga, J. J., Pogłod, R., Rosiek, A., Letowska, M., Yuen, J., Cid, J., Harm, S. K., Adhikari, P.

Get full text

Development of RBC transfusion indications and the collection of patient‐specific pre‐transfusion information: summary by Yazer, M. H., Watering, L., Lozano, M., Sirdesai, S., Rushford, K., Wood, E. M., Yokoyama, A. P., Kutner, J. M., Lin, Y., Callum, J., Cserti‐Gazdewich, C., Lieberman, L., Pendergrast, J., Pendry, K., Murphy, M. F., Selleng, K., Greinacher, A., Marwaha, N., Sharma, R., Jain, A., Orlin, Y., Yahalom, V., Perseghin, P., Incontri, A., Masera, N., Okazaki, H., Ikeda, T., Nagura, Y., Zwaginga, J. J., Pogłod, R., Rosiek, A., Letowska, M., Yuen, J., Cid, J., Harm, S. K., Adhikari, P.

Get full text

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma by Mithraprabhu, Sridurga, Sirdesai, Shreerang, Chen, Maoshan, Khong, Tiffany, Spencer, Andrew

“…Mutational characterisation in extramedullary multiple myeloma (EM-MM) patients is challenging due to inaccessible EM plasmacytomas, unsafe nature of multiple…”
Get full text

The Increasing Recognition of Transthyretin Cardiac Amyloidosis (ATTR-CA): Patient Characteristics and Survival in the Australian Context by Choi, B., Lasica, M., Huynh, N., Sirdesai, S., Nagarethinam, M., Ting, S., Cooke, J., Hare, J., Gibbs, S.

Get full text

Diflunisal Significantly Improves Survival of Patients With Transthyretin (TTR) Amyloidosis Cardiomyopathy (ATTR-CM); A Retrospective Analysis by Choi, B., Lasica, M., Huynh, N., Sirdesai, S., Nagarethinam, M., Ting, S., Cooke, J., Hare, J., Gibbs, S.

Get full text

Bacteriophage Intervention Effectively Kills Listeria on Food Contact Surface Materials by Sirdesai, S., De Vegt, B., Peterson, R., Moncho, A., Van Mierlo, J.

“…ObjectivesListeria is a pathogenic bacterium that is widespread in nature and can enter food processing plants through many vectors, like raw materials,…”
Get full text

Efficieny of Phage Intervention Against Salmonella in Meat and Poultry Processing by De Vegt, B., Sirdesai, S., Peterson, R., Pinheiro, M., Nuboer, W., Kan, A., Van Mierlo, J.

“…ObjectivesPathogen Reduction, Hazard Analysis, and Critical Control Point systems final rule mandates establishments to seek and adopt antimicrobial…”
Get full text

Efficieny of Phage Intervention Against Salmonella in Meat and Poultry Processing by Vegt, B. De, Sirdesai, S., Peterson, R., Pinheiro, M., Nuboer, W., Kan, A., Mierlo, J. Van

Get full text

Bacteriophage Intervention Effectively Kills Listeria on Food Contact Surface Materials by Sirdesai, S., Vegt, B. De, Peterson, R., Moncho, A., Mierlo, J. Van

Get full text

PS1381 A PHASE 2 TRIAL OF THE COMBINATION OF IXAZOMIB, THALIDOMIDE AND DEXAMETHASONE (ITD) IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA – THE AMARC 16–02 TRIAL by Bergin, K., Yuen, F., Wallington‐Bedoe, C., Kalff, A., Sirdesai, S., Reynolds, J., Spencer, A.

“…Background: Despite improved survival outcomes in multiple myeloma (MM) relapse is inevitable and further therapeutic options are required for patients with…”
Get full text

Efficiency of Phage Intervention on Salmonella Kill on Lean Pork, Pork Trim and Bacon by Sirdesai, S., Eraclio, G., Peterson, R., Mierlo, J. van, Vegt, B. De

Get full text

Synergistic Effect of Phages and Organic Acid Salts on Listeria Contaminated Ready to Eat Turkey Ham by Eraclio, G., Vegt, B. De, Mierlo, J. van, Sirdesai, S., Peterson, R.

Get full text

PF604 THE AUSTRALASIAN LEUKAEMIA AND LYMPHOMA (ALLG) GROUP MM17 TRIAL: RESPONSE ADAPTIVE SALVAGE WITH CARFILZOMIB‐THALIDOMIDE‐DEXAMETHASONE FOR MULTIPLE MYELOMA PATIENTS FAILING FRONT‐LINE BORTEZOMIB by Spencer, A., Quach, H., Horvath, N., Kerridge, I., Yuen, F., Lee, E., Morris, E., Kalff, A., Bergin, K., Sirdesai, S., Gorniak, M., Mithraprabhu, S., Khong, T., Reynolds, J.

“…Background: Over 90% of transplant eligible newly diagnosed multiple myeloma (TE‐NDMM) patients (pts) in Australia are induced with bortezomib (V)‐…”
Get full text